BioNano Genomics Inc vs Match Group Inc — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Match Group Inc trades at $37 (market cap $8.45B). The key difference: Match Group Inc is far larger — about 618.6× BioNano Genomics Inc's market cap, and Match Group Inc pays a 2.17% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MTCH | |
|---|---|---|
Market Cap | $13.66M | $8.45B |
Sector | Health | Media |
52-Week High | $4.92 | $41.24 |
52-Week Low | $1.06 | $28.90 |
Enterprise Value | $16.26M | $11.42B |
Dividend Yield | — | 2.17% |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →